IP Verse

Anti-Pd-L1 Combinations For Treating Tumors

Patent No. EP3166976 (titled "Anti-Pd-L1 Combinations For Treating Tumors") was filed by Birdie Biopharmaceuticals on Jul 8, 2015. The application was issued on Feb 23, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PATENT BOUTIQUENov 23, 2022-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3166976

BIRDIE BIOPHARMACEUTICALS
Application Number
EP15819519A
Filing Date
Jul 8, 2015
Status
Granted And Under Opposition
Jan 21, 2022
Publication Date
Feb 23, 2022
External Links
Slate, Register , Google Patents